Optimizing Therapies Using Therapeutic Drug Monitoring: Current Strategies and Future Perspectives
Author:
Funder
Medical Research Council
Publisher
Elsevier BV
Subject
Gastroenterology,Hepatology
Reference100 articles.
1. STRIDE-II: an update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): determining therapeutic goals for treat-to-target strategies in IBD;Turner;Gastroenterology,2021
2. How, when, and for whom should we perform therapeutic drug monitoring?;Vermeire;Clin Gastroenterol Hepatol,2020
3. Review article: dose optimisation of infliximab for acute severe ulcerative colitis;Hindryckx;Aliment Pharmacol Ther,2017
4. Optimising use of thiopurines in inflammatory bowel disease;Dart;Expert Rev Clin Immunol,2017
5. Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease;Dubinsky;Gastroenterology,2000
Cited by 51 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Pharmacokinetics of S1P receptor modulators in the treatment of ulcerative colitis;Expert Opinion on Drug Metabolism & Toxicology;2024-09-12
2. When Perfect Is the Enemy of Good: Results of a RAND Appropriateness Panel on Treat to Target in Asymptomatic Inflammatory Bowel Disease;American Journal of Gastroenterology;2024-07-15
3. What are the benefits of therapeutic drug monitoring in the optimization of adalimumab therapy? a systematic review and meta-analysis up to 2022;Frontiers in Pharmacology;2024-07-08
4. Relationship between Ustekinumab trough concentrations and clinical, biochemical and endoscopic outcomes in Crohn’s disease: A multi-center nationwide retrospective study (TARGET STUDY);Medicine;2024-07-05
5. Phytoconstituent-derived nano-medicines/vesicles providing a promising dawn for inflammatory bowel disease;Chinese Chemical Letters;2024-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3